Date post: | 03-Jan-2016 |
Category: |
Documents |
Upload: | amberlynn-chambers |
View: | 227 times |
Download: | 0 times |
• Case presentation• Introduction• Epidemiology• Classification• Aetiology• Clinical presentation• Investigation• treatment• conclusion
CASE PRESENTATION
• A. R.
• 55yr, H/Wife.
• Refered Yusuf Dantsoho Hospital.
• PC-Cough x5/12
• -Haemoptysis x5/12
• -Dyspnoea x5/12
• -Lt Chest pain x4/12
• Cough-distressing, non paroxysmal,• mucoid sputum,• -not posture related• Associated with –• - haemoptysis 50ml/day• -low grade fever, night sweat.• -no weight loss, contact with PTB pt.• -Lt chest pain• Dyspnoea-progressive .
• No history of exposure to Asbestosis, irradiation.
• Does not smoke cigarret.
• No FHx .
• Other systemic review not contributory.
• General physical examination.
• Chest-RR-20/min SPO2 97%• -Chest tube insitu Rt 5ICS• -Deviated trachea Rt • -decreased Lt chest expansion, tactile fremitus• -dull Lt PN,decreased BS.
• Other Systemic Review-
• Sputum AFB- -ve
• Pleural fluid.
• Pleural biopsy.
• Abdominal USS.
• ESR-60mm/hr
• Pcv-36%.
• WBC-9x10 N-60% L-34% M-6%.
INTRODUCTION
• Most common primary tumor of Pleura are benign and malignant Mesothelioma.
• Mesothelioma are malignancy of mesothelia cells lining pleural cavity.
• Often present as malignant effusion.• Less common are sarcoma, lymphoma,
etc.• Virtually all cancers metastasize to pleura.• Asbestos exposure implicative.
Epidemiology
• 2500-3000 cases /day. (US)• 0.1-0.2 /100,000 population.• 3-4 cases /yr in ABUTH• 2-10 folds in Asbestos polluted area.• Race-no predilection.• Sex- M:F 3:1• Age-5-7 decade.• -20-40yr post exposure.
AETIOLOGY
• Asbestos- amphibole, crocidolite
• Erionite.
• Radiation, thorium dioxide.
• Loss of one copy of chromosome 22.
• SV40 Virus
Clinical features
• Asymptomatic.
• Cough.
• Chest pain.(50-90%)
• Dyspnoea.
• Haemptysis.
• +/- weight loss.
• Exposure to Asbestos.
• VATs and biopsy.
• Pleural fluid-typically not diagnostic.
• Pleural biopsy-diagnostic in 98%.
• immunohistochemistry.
• Stage I - Completely resected within the capsule of the parietal pleura without adenopathy (ie, ipsilateral pleura, lung, pericardium, diaphragm, or chest wall disease limited to previous biopsy sites)
• Stage II - All stage I characteristics, with positive resection margins, intrapleural adenopathy, or a combination
• Stage III - Local extension of disease into the chest wall or mediastinum, into the heart, through the diaphragm or peritoneum, or extrapleurally to involve the lymph nodes
• Stage IV - Distant metastatic disease
TREATMENT
• Surgery-Extrapleural pneumonectomy.
-Decortication.
Radiotherapy.
Chemotherapy.
Trimodality.
Prognosis